New insights concerning methicillin-resistant Staphylococcus aureus disease

Clinical Microbiology and Infection

Volumn 15, Issue 2, 2009, Pages 109-111

  Cauda, R ^a   Garau, J ^b  

^a CATHOLIC UNIVERSITY   (Italy)

^b HOSPITAL MÚTUA DE TERRASSA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; DALBAVANCIN; DAPTOMYCIN; LINEZOLID; POLYPEPTIDE ANTIBIOTIC AGENT; TEICOPLANIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; CENTRAL VENOUS CATHETERIZATION; DISEASE DURATION; DISEASE SURVEILLANCE; DRUG EFFICACY; DRUG EXPOSURE; DRUG TREATMENT FAILURE; EDITORIAL; ENDOTRACHEAL INTUBATION; ENTERIC FEEDING; HAND WASHING; HOSPITAL HYGIENE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; PATIENT ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; STAPHYLOCOCCUS INFECTION;

METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;

EID: 62149146533     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2009.02700.x     Document Type: Editorial

References (19)

1. Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006; 5: 2.
2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: A meta-analysis. Clin Infect Dis 2003; 36: 53-59.
3. Whitby M, McLaws ML, Berry G. Risk of death from methicillin-resistant Staphylococcus aureus bacteraemia: A meta-analysis. Med J Aust 2001; 175: 264-267.
4. McHugh CG, Riley LW. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 2004; 25: 425-430.
5. Graffunder EM, Venezia RA. Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials. J Antimicrob Chemother 2002; 49: 999-1005.
6. Grundmann H, Hori S, Winter B et.al. Risk factors for the transmission of methicillin-resistant Staphylococcus aureus in an adult intensive care unit: Fitting a model to the data. J Infect Dis 2002; 185: 481-488.
7. Campbell AL, Bryant KA, Stover B et al. Epidemiology of methicillin-resistant Staphylococcus aureus at a children's hospital. Infect Control Hosp Epidemiol 2003; 24: 427-430.
8. Ho PL for the Hong Kong intensive care unit antimicrobial resistance study (HK-ICARE) group. Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission. Crit Care Med 2003; 31: 1175-1182.
9. British Society for Antimicrobial Chemotherapy, Hospital Infection Society and the Infection Control Nurses Association. Working Party Report. Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. J Hosp Infect 1998; 39: 253-290.
10. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999; 20: 250-278.
11. Cooper BS, Stone SP, Kibbler CC et al. Isolation measures in the hospital management of methicillin resistant Staphylococcus aureus (MRSA): Systematic review of the literature. BMJ 2004; 329: 533-538.
12. Tacconelli E, Venkataraman L, De Girolami PC, D'Agata EM. Methicillin-resistant Staphylococcus aureus bacteraemia diagnosed at hospital admission: Distinguishing between community-acquired versus healthcare-associated strains. J Antimicrob Chemother 2004; 53: 474-479.
13. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin-resistant Staphylococcus aureus: A meta-analysis of prevalence and risk factors. Clin Infect Dis 2003; 36: 131-139.
14. Grayson ML, Jarvie LJ, Martin R et al. Hand Hygiene Study Group and Hand Hygiene Statewide Roll-out Group, Victorian Quality Council. Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent successful statewide roll-out. Med J Aust 2008; 188: 633-640.
15. Monnet DL. Methicillin-resistant Staphylococcus aureus and its relationship to antimicrobial use: Possible implications for control. Infect Control Hosp Epidemiol 1998; 19: 552-559.
16. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008; 61: 26-38.
17. Jeyaratnam D, Whitty CJ, Phillips K et al. Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial. BMJ 2008; 336: 927-930.
18. Harbarth S, Fankhauser C, Schrenzel J et al. Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008; 299: 1149-1157.
19. Humphreys H. National guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus - what do they tell us? Clin Microbiol Infect 2007; 13: 846-853.